Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana.

David Kwame DosooKezia MalmFelix Boakye OppongRichard GyasiAbraham OduroJohn WilliamsDorcas AtibillaNana Yaw PeprahMieks TwumasiSeth Owusu-AgyeiBrian GreenwoodDaniel ChandramohanKwaku Poku Asante

Published in: BMJ global health (2021)

There was no difference in the risk of PM, LBW or maternal anaemia among women receiving 3 doses compared with ≥4 doses. Receiving ≥3 IPTp-SP doses during pregnancy was associated with a lower risk of overall PM infection compared with 2 doses. As there are no safety concerns, monthly administration of IPTp-SP offers a more practical opportunity for pregnant women to receive ≥3 doses during pregnancy.

Keyphrases

pregnant women
pregnancy outcomes
particulate matter
air pollution
randomized controlled trial
systematic review
polycystic ovary syndrome
risk assessment
preterm birth
water soluble
weight loss